Almagro P., Barreiro B., Ochoa de Echagüen A., Quintana S., Craballeira M.R., Heredia J.L., Garau J. (2006). Risk Factors for Hospital Readmission in Patients with Chronic Obstructive pulmonary Disease, Respiration 2006, 73: 311-31

(1)

Riferimenti bibliografici

Adams S.G., MD, MS; Smith P.K., RRT; Allan P.F., Anzueto A., MD; Pugh J.A., Cornell J.E., PhD ( 2007). Systematic Review of the Chronic Care Model in Chronic Obstructive Pulmonary Disease Prevention and Management, Arch Intern Med 2007;

167: 551-561.

Almagro P., Barreiro B., Ochoa de Echagüen A., Quintana S., Craballeira M.R., Heredia J.L., Garau J. (2006). Risk Factors for Hospital Readmission in Patients with Chronic Obstructive pulmonary Disease, Respiration 2006, 73: 311-317.

Al-shair K., Muellerova H., Jorke J., Rennard S.I, Wouters E.F.M, A Hanania N., Sharafkhaneh A., VestboJ. ( 2012). Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale, Health and quality of Life Outcomes 2012, 10:100.

Anderson D., MacNee W. (2009). Target treatment in COPD: a multi-system approach for a mulyi-system disease, International Journal of COPD 2009:4 321- 335.

Anzueto A., Miravitlles M., Ewig S., Legnani D., Heldner S., Stauch k. (2012).

Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of

chronic bronchitis and COPD, Respiratory Medicine xx, 1-10.

(2)

Bentsen S.B., Henriksen A.H., Wentzel-Larsen T., Hanestad R.B.& Wahl A.K. (2008).

What determines subjective health status in patients with chronic obstructive pulmonary disease: the importance of symptoms in subjective health status of COPD patients, Health Quality of Life Outcomes 2008, 6:115.

Bjelland I., Dahl A.A., Haug T.T., Neckelmann D. (2001). The validity of the Hospital Anxiety and Depression Scale An update literature review, Journal of Psychosomatic Research 52(2002)69-77.

Bratas O., MSc, Espnes G.A.,PhD, Rannestad T., PhD, & Walstad R. PhD (2009).

Charateristics of patients with chronic obstructive pulmonary disease choosing rehabilitation, J Rehabil Med 2010 42: 362-367.

Brenes G.A., PhD (2003). Anxiety and Chronic Obstructive Pulmonary Disease:

Prevalence, Impact, and Treatment, Psychosomatic Medicine 65: 963-970.

Burge S., Wedzicha J.A. (2003). COPD exacerbations: definitions and classifications, European Respiratory Journal 21: suppl. 41, 46s-53s.

Cafarella P.A., Effing T.W., Usmani Z-A., & Frith P.A. (2012). Treatments for

anxiety and depression in patients with chronic obstructive pulmonary disease: A

literature review, respirology 17, 627-638, doi: 10. 1011/j. 1440-1843.

(3)

Cleland J.A., Lee A.J.& Hall S. (2007). Associations of depression and anxiety with gender, age, healt-related quality of life and symptoms in primary care COPD patients, Family Practice 24:217-223.

Cockcrokt A., Bagnall P., Heslop A., Andersson N., Heaton R., Batstone J., Allen J., Spencer P., Guz A. ( 1987). Controlled trial of respiratory health worker visiting patients with chronic respiratory disability, British Medical Journal Vol. 294.

Coventry P.A., Gemmell I., Todd C.J. (2011). Psychosocial risk factors for hospital readmission in COPD patients on early discharge services: a cohort study, BMC Pulmonary Medicine 11:49.

Curtis J.R., A Deyo R., Hudson L.D. ( 1994). Health-related quality of life among patients with chronic obstructive pulmonary disease, Thorax 1994;49:162-170.

Engström C-P., Persson L-O., Larsson S. & Sullivan M. (1999). Long-term effects of a pulmonary rehabilitation programme in outpatients with chronic obstructive pulmonary disease: a randomized controlled study, Scand J Rehab Med 31: 207- 2013.

Funk G-C., Kirchheiner K., Burghuber O.C. & Hartl S. (2009). BODE index versus

GOLD classification for explaining anxious and depressive symptoms in patients with

COPD- a cross-sectional study, Respiratory Research 2009, 10:1.

(4)

Gallefoss F., Bakke P.S., & Kjærsgaard P. ( 1999). Quality of Life Assessment after Patient Education in a Randomized Controlled Study on Asthma and Chronic Obstructive Pulmonary Disease, AM J Respir Crit Care Med 1999; 159: 812-817.

Garcia-Aymerich J., Lange P., Benet M., Schnohr P., Antò J.M. (2006). Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study, Thorax 2006, 61: 772-778.

Garcia-Aymerich J., Monsò E., Marrades R.M., Escarrabill J., Fèlez M.A., Sunyer J., Antò J.M.& the EFRAM Investigators (2001). Risk Factors for Hospitalization for a Chronic Obstructive Pulmonary Disease Exacerbation, Am J Respir Crit Care Med Vol. 164.pp 1002-1007.

Goeman D., Walters J., Ross C. (2012). Anticipating the outcomes and care choises for people living with COPD, Prymary Care Respiratory Journal 2012; 21(x): x-x.

GOLD : Global Initiative for Chronic Obstructive Lung Disease (2006)

Gore J.M., Brophy C.J., Greenstone M.A.(2000) .How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)?A comparison of palliative care and quality of life in COPD and lung cancer, Thorax 2000;55:1000–

1006.

(5)

Güder G., Brenner S., Angermann C.E., Ertl G., Held M., Sachs A., Lammers J-W., Zanen P., Hoes A.W., Störk & Rutten F. (2012). “ GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort study”, Güder et al. Respiratory Research 2012 13: 13.

Gudmundsson G., Gislason T., Janson C., Lindberg E., Hallin R., Ulrik C.S., Brondum E., Nieminen M.M., Aine T. & Bakke P. (2005). Risk factors for rehospitalisation in COPD: role of healt status, anxiety and depression, , European Respiratory Journal 26: 414-419.

Haave E., Hyland M.E, Engvik (2007). Improvements in exercise capacity during a 4- weeks pulmonary rehabilitation program for COPD patients do not correspond with improvements in self-reported health status or quality of life, International Journal of COPD 2007: 2(3) 355-359.

Habraken J.M., Pols J., Bindels P.JE., Willems D. (2008). The silence of patients with end-stage COPD: a qualitative study, British Journal of General Practice 2008; 58: 844-894.

Harper R, Brazier J E, Waterhouse J C, Walters S J, Jones N M B Howard P,(1997.)Comparison of outcome measures for patients with chronic obstructive pulmonary disease(COPD) in an outpatient setting, Thorax 1997;52:879–887 879.

Herbert T.B., PhD & Cohen S., PhD ( 1993). Stress and Immunity in Humans: A

Meta-Analytic Review, Psychosomatic Medicine 55:364-379.

(6)

Hermiz O., Comino E., Marks G. Daffurn K., Wilson S., Harris M., (2002).

Randomised controlled trial of home based care of patients with chronic obstructive pulmonary disease, BMJ Vol. 325.

Hill K., Geist R., Goldstein R.S.& Lacasse Y. ( 2008). Anxiety and depression in end- stage COPD, European Respiratory Journal 31: 667- 677.

Kessler R., Faller M., Fourgaut G., Mennecier B. & Weitzenblum E. (1999).

Predictive Factors of Hospitalization for Acute Exacerbation in a Series of 64 Patients with Chronic Obstructive Pulmonary Disease, Am J Respir Crit Care Med Vol 159. pp 158-164.

Kunik M.E., MD, MPH; Roundy K., MD; Veazey C., PhD; Souchek J., PhD;

Richardson P., PhD; Wray N.P., MPH; & Stanley M.A., PhD.(2005). Surprisingly High Prevalence of Anxiety and Depression in Chronic Breathing Disorders, CHEST 127: 1205-1211.

Labrecque M, Rabhi K., Laurin C.& al (2011). Can self-management education program for patients with chronic obstructive pulmonary disease improve quality of life?, Can Respir J vol 18 No 5 : e 77-e81.

Laurin C., PhD, Labrecque M., MD, Dupuis G., MD, Bacon S.L., PhD, Cartier A.,

MD, & Lavoie K.L., PhD. (2009). Chronic Obstructive Pulmonary Disease Patients

With Psychiatric Disorders Are at Greater Risk of Exacerbations, Psychosomatic

Medicine 71: 667-674.

(7)

Lewko A., Bidgood P.L. & Garrod R. (2009). Evaluation of psychological predictors of fatigue in patients with COPD, BMC Pulmonary Medicine 2009, 9-47.

Littlejohns P.,Baveystock C.M.,Parnell H.,Jones P.W. (1991). Randomised controlled trial of the effectiveness of a respiratory health worker in reducing impairment, disability, and handicap due to chronic airflow limitation, Thorax 1991;46:559-564.

Lou P., Zhu Y, Chen P., Zhang P., Yu J., Zhang N, Chen Na., Zhang L., Wu H. and Zhao J. (2012). Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross- sectional case control study, BMC Pulmonary Medicine 2012, 12:53.

Mannino D.M., M.D., Homa D.M., PhD., Akinbami L.J., M.D., Ford E.S. M.D., Redd S.C., M.D. (2002). Chronic Obstructive Pulmonari Disease Surveillance--- United States, 1971--2000.

Meier C., Bodenmann G., Mörgeli H., Jenewein J. (2011). Dyadic coping, quality of life, and psychological distress among chronic obstructive pulmonary disease patients and their partners, International Journal of COPD 2011:6 583-596.

Miravitlles ., Ferrer ., Pont ., Zalacain R., Alvarez-Sala J.L., Masa F., Verea H., Murio C., Ros., Vidal R., for the IMPAC Study Group (2004). Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study, Thorax 2004;59:387–395.

Miravitlles M., Anzueto A, Legnani D., Forstmeier L., Fargel M. (2006). Patient’s

perception of exacerbations of COPD- the perceive study, Respiratory Medicine

(2007) 101, 453-460.

(8)

Miravitlles M., Murio C., Guerrero T., on behalf of the DAFNE Study Group (2001).

Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis, European Respiratory Journal 2001; 17: 928-933.

Monninkhof E., van der Valk P., van der Palen J., van Herwaarden C., Partridge M.R., Zielhuis G. (2003). Self-management education for patients with chronic obstructive pulmonary disease: a systematic review, Thorax 2003;58:394–398.

Murray S., Kendall M., Boyd K., Sheikh A. (2005). Illness trajectories and palliative care, BMJ 2005; 330: 1007-11.

Nicolson P. & Anderson P.(2000). The patient’s burden: physical and psychological effects of acute exacerbations of chronic bronchitis, Journal of Antimicrobial Chemiotherapy 45, Topic T2, 25-32.

Pinnock H., Kendall M., Murray S.A, Worth A., Levack P., Porter M., MacNee W., Sheikh A. (2011). Living and dying with severe chronic obstructive pulmonary disease: multi-prospective longitudinal qualitative study, BMJ 2011; 342:d142.

Pommer A.M., Pouwer F., Denollet J., Pop V.JM (2012). Managing co-morbid

depression and anxiety in primary care patients with asthma and/or chronic

obstructive pulmonary disease: study protocol for a Randomized controlled trial,

Pommer& al. trials 2012, 13:6.

(9)

Quint J.K., Baghai-Ravary R., Donaldson G.C. & Wedzicha (2008). Relationship between depression and exacerbations in COPD, European Respiratory Journal 2008: 32: 53-60.

Rand C.S (2005). Patient adherence with COPD therapy, Eur Respir Rev 2005; 14:

96, 97-101.

S.Fan V., MD, MPH; Curtis J.R., MD, MPH, FCCP; Tu S-P., MD, MPH, McDonell M.B., MS; &Fihn S.D., MD, MPH (2002). Using Quality of Life to Predict Hospitalòization and Mortality in Patients With Obstructive Lung Disease, CHEST 2002; 122:429-436.

Seamark D., Seamark C., Halpin D.M., (2007). Palliative care in chronic obstructive pulmonary disease: a review for clinicians, J R Soc Med 2007; 100: 225-233.

Seekles W., Van Straten A., Beekman A., Van Marwijk H., & Cuijpers P. (2009).

Stepped care for depression and anxiety: from primary care to specialized mental Health care: a randomized controlled trial testing the effectivenessof a stepped care program among primary care patients with mood or anxiety disorders, BMC Health Services Research 2009, 9:90.

Seemungal T.A.R., Donaldson G.C., Paul E.A., Bestall J.C., Jeffries D.J. & Wedzicha

J.A. (1998). Effect of Exacerbation on Quality of Life in Patients with Chronic

Obstructive Pulmonary Disease, Am J Respir Crit Care Med, Vol 157. Pp 1418-1422,

1998.

(10)

Seemungal T.AR.Hurst J.R., Wedzicha J.A.(2009). Exacerbation rate, health status and mortality in COPD- a review of potential interventions, International Journal of COPD 2009: 4 203-223.

Smoller J.W., M.D., Pollack M.H., M.D., Systrom D., M.D., Kradin R.L., M.D.

(1998). Sertraline Effects on Dyspnea in Patients With Obstructive Airways Disease, Psychosomatics 39: 24-29.

Suissa S. ( 2006). Statistical Treatment of Exacerbations in Therapeutic Trials of Chronic Obstructive Pulmonary Disease, Am J Respir Crit Care Med Vol 173. pp 842-846.

Tappenburg J.CA, Shaap D., Monninkhof E.M, Bourbeau J., Oene G.h.W-V., Verheij T.JM, Lammers J-W. J & Schrijvers A.JP (2011). How do COPD patients respond to exacerbations?, BMC Pulmonary medicine 2011, 11:43.

Taylor S.J.C., Candy B., Bryar R.M., Ramsay J., Vrijhoef H.J.M., Esmond G., Wedzicha J.A., Griffiths C.J.(2005). Effectivesness of innovations in nurse led chronic disease management for patients with chronic obstructive pulmonary disease: systematic review of evidence, BMJ, doi: 10.1136/bmj.38512.664167.8F.

Tønnesen P., Carrozzi L., Fagerström K.O., Gratziou C., Jimenez-Ruiz C., Nardini

S., Viegi G., Lazzaro C., Campell I.A., Dagli E., West R. (2007). Smoking cessation in

(11)

patients with respiratory diseases: a high priority, integral component of therapy, Eur Respir J. 2007; 29(2):390-417.

Tselebis A., Bratis D., Kosmas E., Harikiopoulou M., Theodorakopoulou E., Dumitru S., Moussas G., Karkanias A., Ilias I., Siafakas N., Vgontzas A. & Tzanakis N. (2011).

Psychological symptom patterns and vital exhaustion in outpatients with chronic obstructive pulmonary disease, Annals of General Psychiatry 2011, 10:32.

Tsiligianni I., Kocks J., Tzanakis N., Siafakas N. Van der Molen, T.( 2011). Factors that influence disease-specific quality of life or healt status in patients with COPD: a systematic review and meta-analysis of Pearson Correlations, Prim Care Respir J 2011; 20(3): 257-268.

Usmani Z.A., Carson K.V., Cheng J.N., Esterman A.J., Smith B.J. (2011).

Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease, Cochrane Database of Systematic Reviews 2011, Issue 11. Art. No.: CD008483.

Watson P.B., Town G.I., Holbrook N., Dwan C., Toop L.J., Drennan C.J. (1997).

Evaluation of a self-management plan for chronic obstructive pulmonary disease,

Eue Respir J 1997; 10: 1267-1271.

(12)

White P., White S., Edmonds P., Gyseles M., Moxham J., Seed P. & Shipman C.

(2011). Palliative care or end-of-life care in advanced chronic obstructive pulmonary disease, British Journal of General Practice.

Wigal J.K., Creer T.L.& Kostes H. (1991). The COPD Self-Efficacy Scale, CHEST 1991; 99; 1193-1196.

Wong C.J., Goodridge D., Marciniuk D.D., Rennie D. (2010). Fatigue in patients with COPD participating in a pulmonary rehabilitation program, International Journal of Chronic Obstructive pulmonary Dease 2010:5 319-326.

Xu W., Collet J-P., Shapiro S., Lin Y., Yang T., Platt R.W., Wang C. & Bourbeau J.(2008). Independent Effect of Depression and Anxiety on Chronic Obstructive Pulmonary Disease Exacerbations and Hospitalizations, Am J Respir Crit Care Med Vol 178. Pp 913-920.

Zigmond A.S.& Snaith R.P. (1983). The Hospital Anxiety and Depression Scale, Acta

Psychiatr. Scand. 1983: 67:361-370.